Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
about
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.Metastatic lobular carcinoma of breast mimics primary cervix carcinoma: two case reports and a review of the literature.Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast.Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast.The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.Treatment choices for patients with invasive lobular breast cancer: a doctor survey.MetaDCN: meta-analysis framework for differential co-expression network detection with an application in breast cancer.ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breastInvasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.Immune Infiltration in Invasive Lobular Breast Cancer.
P2860
Q31034941-7EE42529-16FD-4EB4-B629-DACA35B9B1EEQ33843822-0313145C-6AC5-4DDA-B10E-4F2F0C32D411Q36093632-4192EF10-EA6E-4C41-974D-92C61F2CEA08Q37045421-273DAB43-F34E-4D42-BA28-6AAF42C15B87Q37496576-02F6918E-369D-4022-90DB-E2D3592611DBQ38652658-E602301D-B66F-49D7-AACF-976268332A4AQ38702293-18D4B1D0-E618-48DA-957C-1B89BB939EFFQ38747402-A02EC372-0C2F-491B-AEB0-B803C637F2CCQ38997433-FA22805D-7FDD-4AC3-81D6-3323591F35B4Q39057173-1C6BED00-9DF4-4BDC-AC24-C68F838ED7BCQ39218140-F7541E0D-ABE4-442A-885C-73AB409A720DQ40061357-50AE398A-E79C-4E48-8DD1-FE36DC52649EQ41169486-A60065D3-66AC-4A3A-9ED8-6D7772FC31E4Q50145963-CCFD2025-AEC6-4EB3-9820-1D56F492AE69
P2860
Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Invasive lobular breast cancer ...... or systemic therapy decisions?
@en
type
label
Invasive lobular breast cancer ...... or systemic therapy decisions?
@en
prefLabel
Invasive lobular breast cancer ...... or systemic therapy decisions?
@en
P2093
P1476
Invasive lobular breast cancer ...... or systemic therapy decisions?
@en
P2093
Anita Wolfer
Franck Bonnetain
Gilles Romieu
Maryse Fiche
Pierre Fumoleau
Séverine Guiu
William Jacot
P304
P356
10.1016/J.CRITREVONC.2014.07.003
P577
2014-07-30T00:00:00Z